Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Kazia Therapeutics ADR

Start price
Target price
Perf. (%)
€10.50
19.11.20
-
19.11.21
-28.57%
19.11.21

Risky Investment
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€24.07
18.10.21
€36.00
18.10.22
31.49%
17.11.21

Revenue growth >5% per year expected
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Risky balance sheet
buy
Nanorepro AG

Start price
Target price
Perf. (%)
€3.38
26.11.20
-
16.11.21
198.22%
17.11.21

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Revenue growth >5% per year expected
Lower EBIT Margin than peer group
Aptevo Therapeutics Inc.

Start price
Target price
Perf. (%)
€35.20
16.11.20
-
16.11.21
-77.34%
17.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Alterity Therapeutics Ltd. ADR

Start price
Target price
Perf. (%)
€25.50
16.11.20
-
16.11.21
-60.78%
17.11.21

Probably not worthwhile Investment
buy
Aptevo Therapeutics Inc.

Start price
Target price
Perf. (%)
€42.00
19.11.20
€50.00
19.11.21
-67.07%
07.11.21

Could be very worthwhile Investment >20% year
buy
Rewalk Robotics Ltd.

Start price
Target price
Perf. (%)
€1.19
05.10.21
-
05.10.22
41.25%
05.11.21

Could be worthwhile Investment >10% per year
Bio-Gate AG

Start price
Target price
Perf. (%)
€5.90
04.11.20
-
04.11.21
-32.20%
05.11.21

Growths faster than the competition
Few uniques
Dependend from some customers or products
Probably not worthwhile Investment
buy
BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€2.46
03.11.20
€3.50
04.11.21
-4.88%
05.11.21

Could be worthwhile Investment >10% per year
Novacyt S.A.

Start price
Target price
Perf. (%)
€10.10
19.10.20
-
04.11.21
-72.31%
05.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Vaxart Inc.

Start price
Target price
Perf. (%)
€6.10
27.09.20
-
04.11.21
-1.25%
05.11.21

Higher risks for its business
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€9.90
22.09.20
-
04.11.21
-49.70%
05.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Edesa Biotech Inc

Start price
Target price
Perf. (%)
€6.15
21.09.20
€4.00
04.11.21
17.07%
05.11.21

Probably not worthwhile Investment
High valuation
buy
Vaxart Inc.

Start price
Target price
Perf. (%)
€4.22
09.09.20
€8.00
04.11.21
42.75%
05.11.21

Could be worthwhile Investment >10% per year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€2.66
13.08.20
€25.00
04.11.21
975.97%
05.11.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Achieve Life Sciences Inc.

Start price
Target price
Perf. (%)
€9.61
31.07.20
-
04.11.21
-19.91%
05.11.21

Precipio Inc

Start price
Target price
Perf. (%)
€5.95
30.07.20
€1.00
04.11.21
-65.88%
05.11.21

buy
Purple Biotech Ltd. ADR

Start price
Target price
Perf. (%)
€7.10
11.07.20
€6.00
04.11.21
-43.38%
05.11.21

Could be worthwhile Investment >10% per year
Innovative
Good culture
buy
Biocorp Production S.A.

Start price
Target price
Perf. (%)
€25.90
09.07.20
€25.00
04.11.21
11.97%
05.11.21

Could be worthwhile Investment >10% per year
buy
Star Equity Holdings Inc.

Start price
Target price
Perf. (%)
€2.48
14.06.20
€5.00
04.11.21
-8.87%
05.11.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Eurobio scientific

Start price
Target price
Perf. (%)
€7.42
06.06.20
€20.00
04.11.21
131.94%
05.11.21

Could be worthwhile Investment >10% per year
buy
Burcon Nutrascience Corp.

Start price
Target price
Perf. (%)
€1.01
28.04.20
€1.00
04.11.21
35.05%
05.11.21

Could be very worthwhile Investment >20% year
buy
Crossject S.A.

Start price
Target price
Perf. (%)
€1.35
22.03.20
€4.00
04.11.21
123.70%
05.11.21

Could be worthwhile Investment >10% per year
buy
Eckert-Ziegler Bg

Start price
Target price
Perf. (%)
-
17.03.20
€220.00
04.11.21
-
05.11.21

Could be worthwhile Investment >10% per year
buy
Heidelberg Pharma AG

Start price
Target price
Perf. (%)
€2.68
16.03.20
€3.00
04.11.21
120.15%
05.11.21

Could be worthwhile Investment >10% per year